drugset / Trial / NCT06481306
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.
Timeline
- Start
- 2024-07-17
- Primary completion
- 2028-04-30
- Completion
- 2029-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986470 | Unknown | — | — |
| Background | Famotidine | Other / unclassified | — | — |
| Background | Pantoprazole | Other / unclassified | — | — |